questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Hémoprotéines
Cytochromes
Cytochrome P-450 enzyme system
Famille-2 de cytochromes P450
Limonène hydroxylases
Limonène hydroxylases : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Limonène hydroxylases : Questions médicales les plus fréquentes",
"headline": "Limonène hydroxylases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Limonène hydroxylases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-17",
"dateModified": "2025-04-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Limonène hydroxylases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Famille-2 de cytochromes P450",
"url": "https://questionsmedicales.fr/mesh/D000072467",
"about": {
"@type": "MedicalCondition",
"name": "Famille-2 de cytochromes P450",
"code": {
"@type": "MedicalCode",
"code": "D000072467",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.422.220.453.491"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cytochrome P-450 CYP2C9",
"alternateName": "Cytochrome P-450 CYP2C9",
"url": "https://questionsmedicales.fr/mesh/D065729",
"about": {
"@type": "MedicalCondition",
"name": "Cytochrome P-450 CYP2C9",
"code": {
"@type": "MedicalCode",
"code": "D065729",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.422.220.453.491.500.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cytochrome P-450 CYP2C19",
"alternateName": "Cytochrome P-450 CYP2C19",
"url": "https://questionsmedicales.fr/mesh/D065731",
"about": {
"@type": "MedicalCondition",
"name": "Cytochrome P-450 CYP2C19",
"code": {
"@type": "MedicalCode",
"code": "D065731",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.422.220.453.491.500.700"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Limonène hydroxylases",
"alternateName": "Limonene Hydroxylases",
"code": {
"@type": "MedicalCode",
"code": "D065730",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sasa Liu",
"url": "https://questionsmedicales.fr/author/Sasa%20Liu",
"affiliation": {
"@type": "Organization",
"name": "College of Enology, Northwest A&F University, Yangling, Shaanxi, 712100, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Yuyao Ren",
"url": "https://questionsmedicales.fr/author/Yuyao%20Ren",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Biotechnology, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian, 116023, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Guojie Jin",
"url": "https://questionsmedicales.fr/author/Guojie%20Jin",
"affiliation": {
"@type": "Organization",
"name": "College of Enology, Northwest A&F University, Yangling, Shaanxi, 712100, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Xiaobing Yang",
"url": "https://questionsmedicales.fr/author/Xiaobing%20Yang",
"affiliation": {
"@type": "Organization",
"name": "College of Enology, Northwest A&F University, Yangling, Shaanxi, 712100, People's Republic of China. yangxb@nwafu.edu.cn."
}
},
{
"@type": "Person",
"name": "Elham Zarenezhad",
"url": "https://questionsmedicales.fr/author/Elham%20Zarenezhad",
"affiliation": {
"@type": "Organization",
"name": "Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Interstitial ectopic pregnancy successfully treated with methotrexate.",
"datePublished": "2023-04-26",
"url": "https://questionsmedicales.fr/article/37185311",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bcr-2022-252588"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hepatic Superscan in Methotrexate-Associated Lymphoproliferative Disorder.",
"datePublished": "2023-04-24",
"url": "https://questionsmedicales.fr/article/37083567",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/RLU.0000000000004647"
}
},
{
"@type": "ScholarlyArticle",
"name": "Methotrexate in generalized myasthenia gravis: a systematic review.",
"datePublished": "2023-03-27",
"url": "https://questionsmedicales.fr/article/36967437",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s13760-023-02242-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Application and pharmacological mechanism of methotrexate in rheumatoid arthritis.",
"datePublished": "2022-05-05",
"url": "https://questionsmedicales.fr/article/35658215",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.biopha.2022.113074"
}
},
{
"@type": "ScholarlyArticle",
"name": "Low-Dose Intravitreal Methotrexate for Proliferative Vitreoretinopathy.",
"datePublished": "2023-03-01",
"url": "https://questionsmedicales.fr/article/36944071",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3928/23258160-20230220-01"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hémoprotéines",
"item": "https://questionsmedicales.fr/mesh/D006420"
},
{
"@type": "ListItem",
"position": 5,
"name": "Cytochromes",
"item": "https://questionsmedicales.fr/mesh/D003580"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cytochrome P-450 enzyme system",
"item": "https://questionsmedicales.fr/mesh/D003577"
},
{
"@type": "ListItem",
"position": 7,
"name": "Famille-2 de cytochromes P450",
"item": "https://questionsmedicales.fr/mesh/D000072467"
},
{
"@type": "ListItem",
"position": 8,
"name": "Limonène hydroxylases",
"item": "https://questionsmedicales.fr/mesh/D065730"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Limonène hydroxylases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Limonène hydroxylases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Limonène hydroxylases",
"description": "Comment diagnostiquer une déficience en limonène hydroxylases ?\nQuels tests sont utilisés pour évaluer l'activité des limonène hydroxylases ?\nLes symptômes peuvent-ils indiquer un problème avec les limonène hydroxylases ?\nY a-t-il des biomarqueurs associés aux limonène hydroxylases ?\nComment les tests génétiques aident-ils au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D065730?mesh_terms=Methotrexate&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Limonène hydroxylases",
"description": "Quels symptômes sont liés à une déficience en limonène hydroxylases ?\nLes symptômes varient-ils selon les individus ?\nPeut-on observer des symptômes cutanés ?\nLes symptômes respiratoires sont-ils fréquents ?\nY a-t-il des symptômes neurologiques associés ?",
"url": "https://questionsmedicales.fr/mesh/D065730?mesh_terms=Methotrexate&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Limonène hydroxylases",
"description": "Peut-on prévenir les troubles liés aux limonène hydroxylases ?\nY a-t-il des mesures diététiques préventives ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nL'éducation sur les allergies est-elle importante ?\nLes environnements de travail peuvent-ils influencer la santé ?",
"url": "https://questionsmedicales.fr/mesh/D065730?mesh_terms=Methotrexate&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Limonène hydroxylases",
"description": "Quels traitements sont disponibles pour les troubles liés aux limonène hydroxylases ?\nLa thérapie génique est-elle une option ?\nDes médicaments spécifiques existent-ils ?\nComment la nutrition peut-elle aider ?\nLes traitements alternatifs sont-ils efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D065730?mesh_terms=Methotrexate&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Limonène hydroxylases",
"description": "Quelles complications peuvent survenir avec une déficience en limonène hydroxylases ?\nLes complications sont-elles réversibles ?\nY a-t-il des risques à long terme ?\nLes complications affectent-elles la qualité de vie ?\nDes complications neurologiques sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D065730?mesh_terms=Methotrexate&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Limonène hydroxylases",
"description": "Quels sont les facteurs de risque pour les troubles enzymatiques ?\nL'âge influence-t-il le risque de déficience ?\nLes allergies augmentent-elles le risque ?\nY a-t-il des facteurs environnementaux à considérer ?\nLe mode de vie joue-t-il un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D065730?mesh_terms=Methotrexate&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en limonène hydroxylases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des analyses génétiques peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité des limonène hydroxylases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques mesurant l'activité enzymatique dans des échantillons biologiques."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils indiquer un problème avec les limonène hydroxylases ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes métaboliques peuvent suggérer une dysfonction enzymatique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des biomarqueurs associés aux limonène hydroxylases ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des métabolites spécifiques peuvent servir de biomarqueurs pour l'activité enzymatique."
}
},
{
"@type": "Question",
"name": "Comment les tests génétiques aident-ils au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils identifient des mutations dans les gènes codant pour les limonène hydroxylases."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une déficience en limonène hydroxylases ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles métaboliques, des réactions allergiques ou des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les individus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'expression des symptômes peut varier en fonction de la génétique et de l'environnement."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes cutanés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des éruptions cutanées peuvent survenir en raison d'une hypersensibilité."
}
},
{
"@type": "Question",
"name": "Les symptômes respiratoires sont-ils fréquents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme l'asthme peuvent être exacerbés par des métabolites du limonène."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles neurologiques peuvent survenir, mais ils sont moins fréquents."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés aux limonène hydroxylases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais éviter les allergènes peut aider à réduire les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures diététiques préventives ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et riche en nutriments peut soutenir la santé enzymatique."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils aider à la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier les individus à risque et permettre une surveillance précoce."
}
},
{
"@type": "Question",
"name": "L'éducation sur les allergies est-elle importante ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, comprendre les allergies peut aider à éviter les déclencheurs et réduire les risques."
}
},
{
"@type": "Question",
"name": "Les environnements de travail peuvent-ils influencer la santé ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des environnements de travail exposant à des terpènes peuvent augmenter les risques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles liés aux limonène hydroxylases ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements symptomatiques et des modifications diététiques peuvent être recommandés."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche, mais pas encore largement disponible pour ces troubles."
}
},
{
"@type": "Question",
"name": "Des médicaments spécifiques existent-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de médicaments spécifiques pour traiter ces déficiences."
}
},
{
"@type": "Question",
"name": "Comment la nutrition peut-elle aider ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants peut soutenir la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Les traitements alternatifs sont-ils efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines thérapies alternatives peuvent aider à gérer les symptômes, mais peu de preuves."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une déficience en limonène hydroxylases ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications métaboliques et des réactions allergiques sévères peuvent se produire."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques à long terme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des risques de maladies chroniques peuvent augmenter en raison de l'exposition continue."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent significativement impacter la qualité de vie des individus concernés."
}
},
{
"@type": "Question",
"name": "Des complications neurologiques sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, bien que rares, des complications neurologiques peuvent survenir dans certains cas."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles enzymatiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents familiaux et des expositions environnementales peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de déficience ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines déficiences peuvent se manifester plus tard dans la vie."
}
},
{
"@type": "Question",
"name": "Les allergies augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes allergiques peuvent être plus susceptibles de développer des troubles."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à considérer ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des produits chimiques et à des terpènes peut être un facteur de risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie joue-t-il un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque de complications liées aux enzymes."
}
}
]
}
]
}
An ectopic pregnancy (EP) occurs when the fertilised ovum implants outside the endometrial cavity. An EP has an incidence of 1%, with the majority occurring in the fallopian tube. It has a maternal mo...
A 60-year-old man on methotrexate for treatment of adult-onset Still disease presented with acute onset of fever, pancytopenia, and deranged liver function. Besides FDG-avid lesions in spleen and skel...
Current myasthenia gravis guidelines recommend the use of azathioprine as first-line steroid sparing agent. However, due to its high cost, compliance to azathioprine is low in developing countries. To...
Methotrexate (MTX) has been used for the treatment of rheumatoid arthritis (RA) for about forty years and to date MTX remains the part of global standard of treatment for RA. The efficacy of MTX in RA...
Proliferative vitreoretinopathy (PVR) has been mitigated by intravitreal methotrexate (MTX) 400 μg/0.1 mL in several studies. Here, we evaluate the results from a lower dose of MTX, 200 μg/0.05 mL....
We identified and reviewed records of patients with grade ≥C1 PVR who were treated with 200 μg/0.05 mL MTX injections: during PVR surgery and every 2 weeks thereafter....
Twenty-four eyes met inclusion criteria with a mean of 5.6 injections and follow-up ranging 6 to 56 months. The retina was reattached in 19 of 24 eyes (79%) after a single surgery and in 5 of 24 eyes ...
Low-dose MTX (200 μg/0.05 mL) during and after PVR surgery resulted in good rates of retinal reattachment and visual acuity recovery....
Even today methotrexate (MTX) remains the backbone of psoriasis management in dermatological practice. The widespread usage as well as over the counter availability of drug in India has led to frequen...
An otherwise healthy 47-year-old woman presented with confluent pustular lesions on the scalp for 5 months and asymptomatic pustular lesions on the trunk and extremities for 2 weeks. She did not have ...
Non-tubal ectopic pregnancies can be located in the uterine portion of the tube (interstitial or cornual), in the cervix (cervical), in a cesarian scar, in the ovary, or intra-abdominally. Even though...
Keratoacanthoma (KA) is a benign neoplasm that affects mainly photodamaged skin. It is locally destructive and may rarely spread. Surgery is not always suitable and usually disfiguring. Thus, non-oper...
To assess and compare the efficacy of intralesional methotrexate (MTX) and 5-flurouracil (5-FU) in the treatment of KA....
Randomized controlled trial included 20 patients with biopsy proven KA divided into 2 equal groups; group (A) received intralesional MTX, 25 mg/ml and group (B) received intralesional 5-FU, 50 mg/ml e...
In the MTX group, complete clearance was observed in 7 patients (70%) compared to 8 patients (80%) in the 5- FU group with no statistically significant difference. However, the median number of inject...
the small sample size due to the relatively low incidence of KAs in our population....
Intralesional therapy is a good alternative to surgery in selected cases of KA. Both drugs showed comparable efficacy, but 5-FU may give faster results, hence increasing patient satisfaction and compl...
Therapeutic drug monitoring (TDM) has the potential to improve efficacy and diminish side effects. Measuring methotrexate-polyglutamate (MTX-PG) in erythrocytes might enable TDM for methotrexate in pa...
To investigate the relationship between MTX-PGs and methotrexate drug survival, efficacy and toxicity METHODS: In a multicentre prospective cohort study, patients with CD starting subcutaneous methotr...
We included 80 patients with CD (mean age 55 ± 13y, 35% male) with a median FCP of 268 μg/g (IQR 73-480). After the 12-month visit, 21 patients (26%) were still on subcutaneous methotrexate monotherap...
Higher MTX-PG...